On the surface, 2024 could seem like a disappointing year for commercial cannabinoids, but scratch the surface and it really was not all that bad
The UK Food Standards Agency (FSA) board met on 11th December to discuss a recent report on progress towards approval of an ingestible CBD product in the country
The ever-changing make-up of US president-elect Donald Trump’s nominees for posts in his administration – still far from set in stone – offers a few new options that will impact on cannabis and hemp
Not a single US state governorship flipped parties during the elections held on 5th November despite strong gains in the Senate for the Republican party, as well as the party’s victory in the presidential election
While the sector’s optimism about the prospect of a Republican presidency would have barely been imaginable until recently, Donald Trump’s re-election is being welcomed with positive expectations by the country’s cannabis industry
Until last week, the US cannabis sector was wondering what to expect from the then-upcoming presidential elections, and cannabis legalisation was also on the ballot in several states
This report examines the models of recreational cannabis legalisation that are currently being implemented in Europe, their nuances, and the commercial opportunities they may provide
The CannIntelligence policy tracker provides a centralised location to track the most significant global policy reforms in cannabis
As the US cannabis sector prepares for the economic impact of an announced reclassification of marijuana to a less-restrictive schedule, the presidential contest seems to have already turned cannabis into a business opportunity worth supporting
Thailand’s new government has said it will not reclassify cannabis as an illegal drug as it seeks to end a legal limbo that has chilled investor interest in the country’s nascent weed industry
Some fear healthcare and food safety will not be among the main concerns of the next European Commission after the Commission president unveiled the new commissioners’ respective tasks
Democratic US presidential candidate Kamala Harris has become one of the most positive major voices for cannabis liberalisation at the federal level, but critics say her prior record undermines that and leaves her untrustworthy
Republican US presidential nominee Donald Trump may end up an ally of the cannabinoid industry if recent comments on his voting intentions are to be believed